• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 的时间动态和进化表明,加拿大安大略省持续进行病毒基因组测序是必要的。

Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada.

机构信息

Department of Psychiatry, Queen's University, Kingston, Ontario, Canada

Queen's Genomics Lab at Ongwanada (Q-GLO), Ongwanada Resource Centre, Kingston, Ontario, Canada.

出版信息

mSphere. 2021 May 5;6(3):e00011-21. doi: 10.1128/mSphere.00011-21.

DOI:10.1128/mSphere.00011-21
PMID:33952657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8103981/
Abstract

Genome-wide variation in SARS-CoV-2 reveals evolution and transmission dynamics which are critical considerations for disease control and prevention decisions. Here, we review estimates of the genome-wide viral mutation rates, summarize current COVID-19 case load in the province of Ontario, Canada (5 January 2021), and analyze published SARS-CoV-2 genomes from Ontario (collected prior to 24 November 2020) to test for more infectious genetic variants or lineages. The reported mutation rate (∼10 nucleotide [nt] cycle) for SARS-CoV-2 is typical for coronaviruses. Analysis of published SARS-CoV-2 genomes revealed that the G614 spike protein mutation has dominated infections in Ontario and that SARS-CoV-2 lineages present in Ontario have not differed significantly in their rate of spread. These results suggest that the SARS-CoV-2 population circulating in Ontario has not changed significantly to date. However, ongoing genome monitoring is essential for identification of new variants and lineages that may contribute to increased viral transmission.

摘要

全基因组变异的 SARS-CoV-2 揭示了进化和传播动态,这是疾病控制和预防决策的关键考虑因素。在这里,我们评估了全基因组病毒突变率的估计值,总结了加拿大安大略省截至 2021 年 1 月 5 日的 COVID-19 病例数,并分析了安大略省已发表的 SARS-CoV-2 基因组(收集于 2020 年 11 月 24 日之前),以检测更具传染性的遗传变异或谱系。SARS-CoV-2 的报告突变率(约 10 个核苷酸[nt]循环)对于冠状病毒来说是典型的。对已发表的 SARS-CoV-2 基因组的分析表明,G614 刺突蛋白突变主导了安大略省的感染,并且安大略省存在的 SARS-CoV-2 谱系在传播速度上没有显著差异。这些结果表明,到目前为止,安大略省循环的 SARS-CoV-2 种群没有明显变化。然而,持续的基因组监测对于识别可能导致病毒传播增加的新变体和谱系至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/11c83c6f955c/mSphere.00011-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/c31ff51360e2/mSphere.00011-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/d724812b540b/mSphere.00011-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/3c349bfbc502/mSphere.00011-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/11c83c6f955c/mSphere.00011-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/c31ff51360e2/mSphere.00011-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/d724812b540b/mSphere.00011-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/3c349bfbc502/mSphere.00011-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae5/8103981/11c83c6f955c/mSphere.00011-21-f004.jpg

相似文献

1
Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada.SARS-CoV-2 的时间动态和进化表明,加拿大安大略省持续进行病毒基因组测序是必要的。
mSphere. 2021 May 5;6(3):e00011-21. doi: 10.1128/mSphere.00011-21.
2
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.鉴定具有增强致细胞病变和融合作用的 SARS-CoV-2 高频宿主内刺突变异株。
mBio. 2021 Jun 29;12(3):e0078821. doi: 10.1128/mBio.00788-21.
3
Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.SARS-CoV-2 基因变异的进化追踪突显了稳定和不稳定突变之间的复杂平衡。
mBio. 2021 Aug 31;12(4):e0118821. doi: 10.1128/mBio.01188-21. Epub 2021 Jul 20.
4
Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.人冠状病毒 229E 在香港的分子进化及涉及新型人冠状病毒 229E 基因群共感染的致死性 COVID-19 病例。
mSphere. 2021 Feb 10;6(1):e00819-20. doi: 10.1128/mSphere.00819-20.
5
Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.对来自土耳其患者的 SARS-CoV-2 分离株进行基因组特征分析显示,刺突蛋白和 nsp12 蛋白存在新型突变。
J Med Virol. 2021 Oct;93(10):6016-6026. doi: 10.1002/jmv.27188. Epub 2021 Jul 16.
6
The variants question: What is the problem?变体问题:问题是什么?
J Med Virol. 2021 Dec;93(12):6479-6485. doi: 10.1002/jmv.27196. Epub 2021 Jul 28.
7
Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.新型 SARS-CoV-2 变异株的进化、传播模式和突变特征。
mBio. 2021 Aug 31;12(4):e0114021. doi: 10.1128/mBio.01140-21.
8
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
9
Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes.SARS-CoV-2 基因组中宿主内变异性的时空动态。
Nucleic Acids Res. 2022 Feb 22;50(3):1551-1561. doi: 10.1093/nar/gkab1297.
10
Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management.对一个地区的 SARS-CoV-2 基因组进行大规模测序可以提供详细的流行病学信息,并有助于当地疫情管理。
Microb Genom. 2021 Jun;7(6). doi: 10.1099/mgen.0.000589.

引用本文的文献

1
Mutational Patterns Observed in SARS-CoV-2 Genomes Sampled From Successive Epochs Delimited by Major Public Health Events in Ontario, Canada: Genomic Surveillance Study.在加拿大安大略省由重大公共卫生事件界定的连续时期内采集的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组中观察到的突变模式:基因组监测研究
JMIR Bioinform Biotechnol. 2022 Dec 22;3(1):e42243. doi: 10.2196/42243.
2
Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene.新冠病毒(SARS-CoV-2)的基因组多样性可因非结构蛋白14(nsp14)基因的突变而加速。
iScience. 2023 Mar 17;26(3):106210. doi: 10.1016/j.isci.2023.106210. Epub 2023 Feb 16.
3
High-Throughput Adaptable SARS-CoV-2 Screening for Rapid Identification of Dominant and Emerging Regional Variants.

本文引用的文献

1
Detection of the novel SARS-CoV-2 European lineage B.1.177 in Ontario, Canada.在加拿大安大略省检测到新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)欧洲谱系B.1.177 。
J Clin Virol Plus. 2021 Jun;1(1):100010. doi: 10.1016/j.jcvp.2021.100010. Epub 2021 Mar 22.
2
Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada.系统发生基因组学揭示了加拿大安大略省早期 COVID-19 患者中的病毒来源、传播和潜在的合并感染。
Sci Rep. 2021 Feb 12;11(1):3697. doi: 10.1038/s41598-021-83355-1.
3
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
高通量适应性 SARS-CoV-2 筛选用于快速鉴定优势和新兴的区域性变异。
Am J Clin Pathol. 2022 Jun 7;157(6):927-935. doi: 10.1093/ajcp/aqab212.
评估 SARS-CoV-2 刺突突变 D614G 对传染性和致病性的影响。
Cell. 2021 Jan 7;184(1):64-75.e11. doi: 10.1016/j.cell.2020.11.020. Epub 2020 Nov 19.
4
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.没有证据表明 SARS-CoV-2 反复出现的突变会增加传染性。
Nat Commun. 2020 Nov 25;11(1):5986. doi: 10.1038/s41467-020-19818-2.
5
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2.奥地利超级传播事件的基因组流行病学揭示了 SARS-CoV-2 的突变动态和传播特性。
Sci Transl Med. 2020 Dec 9;12(573). doi: 10.1126/scitranslmed.abe2555. Epub 2020 Nov 23.
6
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.SARS-CoV-2 D614G 变异株在体外具有高效复制能力,并可在体内有效传播。
Science. 2020 Dec 18;370(6523):1464-1468. doi: 10.1126/science.abe8499. Epub 2020 Nov 12.
7
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.SARS-CoV-2 病毒在一个主要大都市区的早期传播和大规模第二波疫情的分子结构。
mBio. 2020 Oct 30;11(6):e02707-20. doi: 10.1128/mBio.02707-20.
8
Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the "Confined Virus"?30983个新冠病毒基因组中的基因组多样性与热点突变:朝着研发针对“受限病毒”的通用疫苗迈进?
Pathogens. 2020 Oct 10;9(10):829. doi: 10.3390/pathogens9100829.
9
Low genetic diversity may be an Achilles heel of SARS-CoV-2.低遗传多样性可能是新冠病毒的致命弱点。
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24614-24616. doi: 10.1073/pnas.2017726117. Epub 2020 Sep 21.
10
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.一种 SARS-CoV-2 疫苗候选物可能与所有当前流行的变异株相匹配。
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23652-23662. doi: 10.1073/pnas.2008281117. Epub 2020 Aug 31.